James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 72,414 shares at $43.54 ($3.3M) on 2018-06-04, disclosed to the SEC on 2018-06-06.
Scheduled sale ($3.3M) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.41 | 10,000 | $434K | 13.2% |
| 2 | $43.42 | 8,594 | $373K | 11.3% |
| 3 | $43.54 | 4,052 | $176K | 5.3% |
| 4 | $44.67 | 10,977 | $490K | 14.9% |
| 5 | $45.47 | 2,523 | $115K | 3.5% |
| 6 | $46.07 | 7,552 |
| $348K |
| 10.5% |
| 7 | $46.83 | 12,448 | $583K | 17.7% |
| 8 | $47.57 | 9,639 | $459K | 13.9% |
| 9 | $48.33 | 6,629 | $320K | 9.7% |
| Total | $45.55 avg | 72,414 | $3.3M | 100% |
| Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-07-09 | $399K | — | Filing → |
| GHDX | SELL | 2019-06-10 | $61K | — | Filing → |